NRC Health (NRC) stock
NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/3078% above fair value
$26.16+0.27 (+1.06%)
Close on Nov 18, 2026Market cap $578.65MP/E –Yield 1.99%
NRC Health operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
NRC Health's operating income for the twelve months ending Jun 30, 2026 was $14.74M, down 46.9% year over year. For fiscal 2025 it was $22.59M, down 35.8% from the year before. Over ten years it grew -1.6% a year on average. The highest annual figure on record is $50.27M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.59M | -35.8% |
| FY2024 | Dec 31, 2024 | $35.19M | -12.1% |
| FY2023 | Dec 31, 2023 | $40.05M | -14.0% |
| FY2022 | Dec 31, 2022 | $46.54M | -7.4% |
| FY2021 | Dec 31, 2021 | $50.27M | +17.8% |
| FY2020 | Dec 31, 2020 | $42.68M | -0.8% |
| FY2019 | Dec 31, 2019 | $43.04M | +22.0% |
| FY2018 | Dec 31, 2018 | $35.28M | +3.1% |
| FY2017 | Dec 31, 2017 | $34.22M | +9.7% |
| FY2016 | Dec 31, 2016 | $31.20M | +18.0% |
| FY2015 | Dec 31, 2015 | $26.45M | -6.5% |
| FY2014 | Dec 31, 2014 | $28.30M | +14.1% |
| FY2013 | Dec 31, 2013 | $24.81M | +9.2% |
| FY2012 | Dec 31, 2012 | $22.72M | +21.3% |
| FY2011 | Dec 31, 2011 | $18.74M | +35.2% |
| FY2010 | Dec 31, 2010 | $13.86M | +1.2% |
| FY2009 | Dec 31, 2009 | $13.70M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.24M | -303.9% |
| Q1 FY2026 | Mar 31, 2026 | $5.57M | -35.2% |
| Q4 FY2025 | Dec 31, 2025 | $4.67M | -51.3% |
| Q3 FY2025 | Sep 30, 2025 | $7.74M | -3.0% |
| Q2 FY2025 | Jun 30, 2025 | $1.59M | -82.1% |
| Q1 FY2025 | Mar 31, 2025 | $8.60M | -1.9% |
| Q4 FY2024 | Dec 31, 2024 | $9.59M | -18.1% |
| Q3 FY2024 | Sep 30, 2024 | $7.98M | -19.8% |
| Q2 FY2024 | Jun 30, 2024 | $8.87M | -5.3% |
| Q1 FY2024 | Mar 31, 2024 | $8.76M | -2.8% |
| Q4 FY2023 | Dec 31, 2023 | $11.71M | -4.4% |
| Q3 FY2023 | Sep 30, 2023 | $9.96M | -10.4% |
| Q2 FY2023 | Jun 30, 2023 | $9.37M | -18.5% |
| Q1 FY2023 | Mar 31, 2023 | $9.02M | -22.9% |
| Q4 FY2022 | Dec 31, 2022 | $12.24M | -4.9% |
| Q3 FY2022 | Sep 30, 2022 | $11.11M | -15.4% |
| Q2 FY2022 | Jun 30, 2022 | $11.50M | -6.1% |
| Q1 FY2022 | Mar 31, 2022 | $11.70M | -2.7% |
| Q4 FY2021 | Dec 31, 2021 | $12.87M | +26.4% |
| Q3 FY2021 | Sep 30, 2021 | $13.14M | +9.3% |
| Q2 FY2021 | Jun 30, 2021 | $12.24M | +32.0% |
| Q1 FY2021 | Mar 31, 2021 | $12.02M | +7.4% |
| Q4 FY2020 | Dec 31, 2020 | $10.19M | -14.8% |
| Q3 FY2020 | Sep 30, 2020 | $12.02M | +17.6% |
| Q2 FY2020 | Jun 30, 2020 | $9.28M | -8.6% |
| Q1 FY2020 | Mar 31, 2020 | $11.19M | +4.6% |
| Q4 FY2019 | Dec 31, 2019 | $11.96M | +27.3% |
| Q3 FY2019 | Sep 30, 2019 | $10.22M | +11.5% |
| Q2 FY2019 | Jun 30, 2019 | $10.15M | +30.9% |
| Q1 FY2019 | Mar 31, 2019 | $10.70M | +19.5% |
| Q4 FY2018 | Dec 31, 2018 | $9.40M | +8.5% |
| Q3 FY2018 | Sep 30, 2018 | $9.17M | +28.7% |
| Q2 FY2018 | Jun 30, 2018 | $7.76M | -8.2% |
| Q1 FY2018 | Mar 31, 2018 | $8.96M | -10.3% |
| Q4 FY2017 | Dec 31, 2017 | $8.66M | -2.0% |
| Q3 FY2017 | Sep 30, 2017 | $7.12M | -3.0% |
| Q2 FY2017 | Jun 30, 2017 | $8.45M | – |
| Q1 FY2017 | Mar 31, 2017 | $9.98M | – |
| Q4 FY2016 | Dec 31, 2016 | $8.83M | – |
| Q3 FY2016 | Sep 30, 2016 | $7.34M | – |
See a number that looks wrong?